As result of a query from a reader, the authors reviewed the data in Table 2 of the original article [1] and found a number of errors in the prior construction of this data table. A formatting error has also been noticed in Table 1.
Table 2.
Complications and side effects associated with IUD insertion and tubal sterilization over time
| Copper IUD | LNG IUD | Tubal Sterilization | |
|---|---|---|---|
| Complications/Side Effect | n (%) | n (%) | n (%) |
| Amenorrhea (ICD-9 626.0) | |||
| Total (2006–2011) | 2385 (8.99)ab | 9077 (7.53)ac | 9410 (11.06)bc |
| 2006 | 308 (8.92) | 941 (7.82) | 1638 (11.00) |
| 2007 | 381 (10.02) | 1278 (7.61) | 1614 (10.93) |
| 2008 | 412 (9.21) | 1873 (7.72) | 1700 (11.59) |
| 2009 | 448 (9.20) | 1845 (7.44) | 1658 (11.14) |
| 2010 | 452 (8.62) | 1518 (7.36) | 1429 (10.73) |
| 2011 | 384 (8.20) | 1622 (7.36) | 1371 (10.92) |
| P Value | 0.0775 | 0.4191 | 0.2768 |
| Anemia (ICD-9 280.xx) | |||
| Total (2006–2011) | 595 (2.24)b | 2832 (2.35)c | 2823 (3.32)bc |
| 2006 | 67 (1.94) | 279 (2.32) | 435 (2.92) |
| 2007 | 78 (2.05) | 386 (2.30) | 433 (2.93) |
| 2008 | 106 (2.37) | 538 (2.22) | 492 (3.35) |
| 2009 | 119 (2.44) | 600 (2.42) | 513 (3.45) |
| 2010 | 135 (2.57) | 512 (2.48) | 481 (3.61) |
| 2011 | 90 (1.92) | 517 (2.35) | 469 (3.73) |
| P Value | 0.1496 | 0.5243 | 0.0001 |
| Dysmenorrhea (ICD-9 625.3) | |||
| Total (2006–2011) | 723 (2.73)ab | 3909 (3.24)ac | 3678 (4.32)bc |
| 2006 | 90 (2.61) | 378 (3.14) | 587 (3.94) |
| 2007 | 85 (2.24) | 566 (3.37) | 591 (4.00) |
| 2008 | 132 (2.95) | 723 (2.98) | 598 (4.08) |
| 2009 | 139 (2.86) | 807 (3.25) | 647 (4.35) |
| 2010 | 137 (2.61) | 692 (3.35) | 649 (4.87) |
| 2011 | 140 (2.99) | 743 (3.37) | 606 (4.82) |
| P Value | 0.6388 | 0.1234 | <0.0001 |
| Heavy Menstrual Bleeding (ICD-9 626.2) | |||
| Total (2006–2011) | 1370 (5.16)ab | 10,204 (8.46)ac | 11,381 (13.38)bc |
| 2006 | 204 (5.91) | 1048 (8.71) | 1687 (11.33) |
| 2007 | 198 (5.21) | 1406 (8.37) | 1750 (11.85) |
| 2008 | 224 (5.01) | 1846 (7.60) | 1922 (13.10) |
| 2009 | 256 (5.26) | 1992 (8.03) | 2045 (13.74) |
| 2010 | 261 (4.98) | 1881 (9.11) | 2006 (15.07) |
| 2011 | 227 (4.85) | 2031 (9.22) | 1971 (15.69) |
| P Value | 0.3527 | <0.0001 | <0.0001 |
| Infection (ICD-9 998.5×) | |||
| Total (2006–2011) | 15 (0.06) | 88 (0.07)c | 24 (0.03)c |
| 2006 | 4 (0.12) | 12 (0.10) | 2 (0.01) |
| 2007 | 1 (0.03) | 14 (0.08) | 2 (0.01) |
| 2008 | 6 (0.13) | 15 (0.06) | 7 (0.05) |
| 2009 | 2 (0.04) | 25 (0.10) | 4 (0.03) |
| 2010 | 0 (0.00) | 14 (0.07) | 4 (0.03) |
| 2011 | 2 (0.04) | 8 (0.04) | 5 (0.04) |
| P Value | 0.0543 | 0.1255 | 0.4301 |
| Menorrhagia (ICD-9 627.0) | |||
| Total (2006–2011) | 53 (0.20)ab | 528 (0.44)ac | 640 (0.75)bc |
| 2006 | 12 (0.35) | 48 (0.40) | 88 (0.59) |
| 2007 | 6 (0.16) | 58 (0.35) | 94 (0.64) |
| 2008 | 11 (0.25) | 84 (0.35) | 92 (0.63) |
| 2009 | 12 (0.25) | 89 (0.36) | 119 (0.80) |
| 2010 | 8 (0.15) | 121 (0.59) | 121 (0.91) |
| 2011 | 4 (0.09) | 128 (0.58) | 126 (1.00) |
| P Value | 0.1181 | <0.0001 | <0.0001 |
| Ovarian Cyst (ICD-9 620.2) | |||
| Total (2006–2011) | 1157 (4.36)ab | 6340 (5.26)ac | 6063 (7.13)bc |
| 2006 | 140 (4.05) | 539 (4.48) | 1045 (7.02) |
| 2007 | 155 (4.08) | 786 (4.68) | 990 (6.70) |
| 2008 | 211 (4.72) | 1268 (5.22) | 1076 (7.34) |
| 2009 | 209 (4.29) | 1400 (5.64) | 1039 (6.98) |
| 2010 | 223 (4.25) | 1142 (5.53) | 1003 (7.53) |
| 2011 | 219 (4.68) | 1205 (5.47) | 910 (7.25) |
| P Value | 0.5197 | <0.0001 | 0.0975 |
| Pelvic Inflammatory Disease (ICD-9 614.xx-616.xx) | |||
| Total (2006–2011) | 93 (0.35) | 334 (0.28)c | 319 (0.37)c |
| 2006 | 13 (0.38) | 40 (0.33) | 64 (0.43) |
| 2007 | 12 (0.32) | 53 (0.32) | 66 (0.45) |
| 2008 | 23 (0.51) | 74 (0.30) | 69 (0.47) |
| 2009 | 15 (0.31) | 60 (0.24) | 54 (0.36) |
| 2010 | 12 (0.23) | 49 (0.24) | 41 (0.31) |
| 2011 | 18 (0.38) | 58 (0.26) | 25 (0.20) |
| P Value | 0.282 | 0.3727 | 0.02 |
| Pelvic Pain (ICD-9 625.9, 789.00) | |||
| Total (2006–2011) | 3222 (12.15)ab | 13,891 (11.52)ac | 11,750 (13.81)bc |
| 2006 | 384 (11.12) | 1395 (11.60) | 1987 (13.35) |
| 2007 | 466 (12.25) | 1915 (11.41) | 1997 (13.52) |
| 2008 | 519 (11.60) | 2729 (11.24) | 1976 (13.47) |
| 2009 | 627 (12.88) | 2897 (11.68) | 2117 (14.23) |
| 2010 | 661 (12.60) | 2419 (11.72) | 1881 (14.13) |
| 2011 | 565 (12.07) | 2536 (11.51) | 1792 (14.27) |
| P Value | 0.1449 | 0.617 | 0.0593 |
| Perforation of Uterine Wall (ICD-9 621.8, 665.3) | |||
| Total (2006–2011) | 412 (1.55)ab | 1558 (1.29)ac | 555 (0.65)bc |
| 2006 | 40 (1.16) | 142 (1.18) | 57 (0.38) |
| 2007 | 51 (1.34) | 176 (1.05) | 76 (0.51) |
| 2008 | 48 (1.07) | 301 (1.24) | 91 (0.62) |
| 2009 | 88 (1.81) | 319 (1.29) | 119 (0.80) |
| 2010 | 98 (1.87) | 307 (1.49) | 103 (0.77) |
| 2011 | 87 (1.86) | 313 (1.42) | 109 (0.87) |
| P Value | 0.0014 | 0.0023 | <0.0001 |
abcChi square pairwise comparisons between groups with the same superscript, p < 0.05. The pairwise comparisons were done for the total for each complication/side effect across years 2006–2011 and not for the individual years
Table 1.
Rate of IUD insertion and tubal sterilization over time
| Copper IUD | LNG IUD | Tubal Sterilization | ||
|---|---|---|---|---|
| Year | Total N | n (%) | n (%) | n (%) |
| 2006 | 1,907,748 | 3454 (0.18) | 12,028 (0.63) | 14,887 (0.78) |
| Age 15 to 19 y | 293,354 | 52 (0.02) | 216 (0.07) | 38 (0.01) |
| Age 20 to 24 y | 220,950 | 330 (0.15) | 1257 (0.57) | 451 (0.20) |
| Age 25 to 34 y | 566,152 | 1735 (0.31) | 6230 (1.10) | 6642 (1.17) |
| Age 35 to 45 y | 827,292 | 1337 (0.16) | 4325 (0.52) | 7756 (0.94) |
| 2007 | 1,940,301 | 3803 (0.20) | 16,789 (0.87) | 14,769 (0.76) |
| Age 15 to 19 y | 299,599 | 79 (0.03) | 416 (0.14) | 42 (0.01) |
| Age 20 to 24 y | 224,324 | 403 (0.18) | 1813 (0.81) | 444 (0.20) |
| Age 25 to 34 y | 583,955 | 1964 (0.34) | 8533 (1.46) | 6471 (1.11) |
| Age 35 to 45 y | 832,423 | 1357 (0.16) | 6027 (0.72) | 7812 (0.94) |
| 2008 | 2,001,739 | 4474 (0.22) | 24,276 (1.21) | 14,667 (0.73) |
| Age 15 to 19 y | 308,311 | 102 (0.03) | 690 (0.22) | 21 (0.01) |
| Age 20 to 24 y | 237,192 | 455 (0.19) | 2845 (1.2) | 410 (0.17) |
| Age 25 to 34 y | 615,537 | 2368 (0.38) | 12,545 (2.04) | 6473 (1.05) |
| Age 35 to 45 y | 840,699 | 1549 (0.18) | 8196 (0.97) | 7763 (0.92) |
| 2009 | 2,016,916 | 4868 (0.24) | 24,811 (1.23) | 14,881 (0.74) |
| Age 15 to 19 y | 312,431 | 93 (0.03) | 777 (0.25) | 37 (0.01) |
| Age 20 to 24 y | 237,723 | 460 (0.19) | 2920 (1.23) | 394 (0.17) |
| Age 25 to 34 y | 625,323 | 2578 (0.41) | 12,614 (2.02) | 6232 (1.00) |
| Age 35 to 45 y | 841,439 | 1737 (0.21) | 8500 (1.01) | 8218 (0.98) |
| 2010 | 1,870,675 | 5246 (0.28) | 20,639 (1.10) | 13,313 (0.71) |
| Age 15 to 19 y | 289,736 | 142 (0.05) | 677 (0.23) | 37 (0.01) |
| Age 20 to 24 y | 222,812 | 551 (0.25) | 2101 (0.94) | 243 (0.11) |
| Age 25 to 34 y | 574,702 | 2782 (0.48) | 10,316 (1.8) | 5485 (0.95) |
| Age 35 to 45 y | 783,425 | 1771 (0.23) | 7545 (0.96) | 7548 (0.96) |
| 2011 | 1,909,316 | 4682 (0.25) | 22,035 (1.15) | 12,560 (0.66) |
| Age 15 to 19 y | 295,377 | 116 (0.04) | 762 (0.26) | 24 (0.01) |
| Age 20 to 24 y | 265,891 | 601 (0.23) | 2648 (1.00) | 280 (0.11) |
| Age 25 to 34 y | 575,729 | 2451 (0.43) | 10,694 (1.86) | 5102 (0.89) |
| Age 35 to 45 y | 772,319 | 1514 (0.20) | 7931 (1.03) | 7154 (0.93) |
| P Value for Trend Over Time in the Overall Population | <0.0001 | <0.0001 | <0.0001 |
The correct version of Table 1 and Table 2 is published in this erratum.
Reference
- 1.Howard, et al. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion. Reprod Health. 2017;14:70. doi: 10.1186/s12978-017-0334-1. [DOI] [PMC free article] [PubMed] [Google Scholar]